Chimerix Inc (NASDAQ: CMRX) At Current Prices: Is It Worth Investing In?

During the recent session, Chimerix Inc (NASDAQ:CMRX)’s traded shares were 0.5 million, with the beta value of the company hitting 0.90. At the last check today, the stock’s price was $2.99, reflecting an intraday gain of 1.70% or $0.05. The 52-week high for the CMRX share is $3.39, that puts it down -13.38 from that peak though still a striking 74.92% gain since the share price plummeted to a 52-week low of $0.75. The company’s market capitalization is $268.91M, and the average intraday trading volume over the past 10 days was 21.93 million shares, and the average trade volume was 3.59 million shares over the past three months.

Chimerix Inc (NASDAQ:CMRX) trade information

Chimerix Inc (CMRX) registered a 1.70% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.70% in intraday trading to $2.99, hitting a weekly high. The stock’s 5-day price performance is 259.38%, and it has moved by 214.74% in 30 days. Based on these gigs, the overall price performance for the year is 215.23%. The short interest in Chimerix Inc (NASDAQ:CMRX) is 0.65 million shares and it means that shorts have 2.44 day(s) to cover.

Chimerix Inc (CMRX) estimates and forecasts

Statistics show that Chimerix Inc has underperformed its competitors in share price, compared to the industry in which it operates. Chimerix Inc (CMRX) shares have gone up 240.74% during the last six months, with a year-to-date growth rate less than the industry average at -6.45% against 17.10. In the rating firms’ projections, revenue will increase 189.44% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 310.6k as predicted by 5 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 100k by the end of current fiscal year.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 8.31%. While earnings are projected to return -5.05% in 2024.

CMRX Dividends

Chimerix Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Chimerix Inc (NASDAQ:CMRX)’s Major holders

Chimerix Inc insiders own 6.63% of total outstanding shares while institutional holders control 45.90%, with the float percentage being 49.16%. RA CAPITAL MANAGEMENT, L.P. is the largest shareholder of the company, while 78.0 institutions own stock in it. As of 2024-06-30, the company held over 8.8 million shares (or 9.8589% of all shares), a total value of $7.71 million in shares.

The next largest institutional holding, with 4.38 million shares, is of MONACO ASSET MANAGEMENT SAM’s that is approximately 4.9045% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.83 million.

Also, the Mutual Funds coming in first place with the largest holdings of Chimerix Inc (CMRX) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 2.9 shares. This amounts to just over 3.23 percent of the company’s overall shares, with a $8.68 million market value. The same data shows that the other fund manager holds slightly less at 1.31, or about 1.46% of the stock, which is worth about $3.91 million.